Fineline Cube

Follow:
14778 Articles
LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline
CompanyDeals

LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline

Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals
Company

Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals

Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset
CompanyDeals

Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset

Cryofocus Biotechnology Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D
CompanyDeals

Cryofocus Medtech Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D

Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia
CompanyDrug

Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia

Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies
CompanyMedical Device

Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies

Servier and HUST Forge Partnership to Cultivate Innovative Therapies through SHINEDocs Program
CompanyDeals

Servier and HUST Forge Partnership to Cultivate Innovative Therapies through SHINEDocs Program

Innovent Biologics' Picankibart Achieves Positive Results in Phase II UC Study
CompanyDrug

Innovent Biologics’ Picankibart Achieves Positive Results in Phase II UC Study

Bayer AG Launches China Innovation Hub to Boost Local R&D and Global Integration
Company

Bayer AG Launches China Innovation Hub to Boost Local R&D and Global Integration

Lexicon Pharmaceuticals Strikes Licensing Deal with Viatris for Global Expansion of Sotagliflozin
CompanyDeals

Lexicon Pharmaceuticals Strikes Licensing Deal with Viatris for Global Expansion of Sotagliflozin

Johnson & Johnson's Nipocalimab Shows Promise in Treating Adolescent Myasthenia Gravis in Phase II/III Trial
CompanyDrug

Johnson & Johnson’s Nipocalimab Shows Promise in Treating Adolescent Myasthenia Gravis in Phase II/III Trial

NHSA Standardizes NRDL Drug Purchases to Combat Prescription Fraud
Policy / Regulatory

NHSA Standardizes NRDL Drug Purchases to Combat Prescription Fraud